This study aimed to explore 400 mcg sublingual misoprostol as primary treatment in lower-level facilities with no previous experience providing postabortion care. The results demonstrated that misoprostol is a viable option for treatment of incomplete abortion at mid-level facilities.

Access the article.

Published:
Oct. 2012
Type:
Staff Publication
Topic:
Pregnancy Failure
Authors:
Blum, Jennifer, Diop, Ayisha, Blandine, T., Ouattara, A.Z., Coral, A., Hassane, C., Clotaire, H., Dao, B., Lankoande, J., Diop, A., Blum, J.